PATENT CLAIM ANALYSIS

Application Number: 15902690
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-11
Patent Classification: ["514", "023000"]

Abstract:
Provided are compounds, methods, and pharmaceutical compositions for treating Filoviridae virus infections by administering ribosides, riboside phosphates and prodrugs thereof, of Formula IV: The compounds, compositions, and methods provided are particularly useful for the treatment of Marburg virus, Ebola virus and Cueva virus infections.

Claim (Index 27):
The pharmaceutical composition of  claim 25 , wherein\n R e1  is methyl; and R e2  is H or methyl.

Metadata:
- Claim Count in Document: 58.0
- Percentile: 88.0
- Lexical Diversity: 1.55882
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15246240', '14926062', '15267433', '12013640', '14830121']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7396676007703005
- 35 USC 102 Novelty (BERT): 0.5889614033366852
- Combined Prediction Score: 0.7245969810269389
- Mean Citation Score: 334.652744
- Max Citation Score: 450.78598
- Similarity Product: 291.0745930894303

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test